These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7206365)

  • 41. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats.
    Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in dopamine receptors in mouse striatum following morphine treatments.
    de la Baume S; Patey G; Marçais H; Protais P; Costentin J; Schwartz JC
    Life Sci; 1979 Jun; 24(25):2333-42. PubMed ID: 573360
    [No Abstract]   [Full Text] [Related]  

  • 43. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of striatal lesions with kainic acid on morphine-induced "catatonia" and increase of striatal dopamine turnover.
    Havemann U; Winkler M; Genç E; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):44-50. PubMed ID: 7196998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 46. Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitro.
    Brase DA
    J Pharm Pharmacol; 1980 Jun; 32(6):432-3. PubMed ID: 6106680
    [No Abstract]   [Full Text] [Related]  

  • 47. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
    Vaatstra WJ; Eigeman L
    Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
    [No Abstract]   [Full Text] [Related]  

  • 48. Modification of antinociceptive action of morphine by dopamine agonist and antagonist in mice.
    Kamata K; Ogawa K; Kameyama T
    Jpn J Pharmacol; 1985 May; 38(1):113-5. PubMed ID: 4021227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proceedings: Kinetics of 14C-dopamine in isolated rat striatal tissue under the influence of morphine.
    Kuschinsky K; Celsen B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R54. PubMed ID: 4276596
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of morphine on kinetics of 14C-dopamine in rat striatal slices.
    Celsen B; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):159-65. PubMed ID: 4368649
    [No Abstract]   [Full Text] [Related]  

  • 51. Test conditions influence the response to a drug challenge in rodents.
    Harkin A; Kelly JP; Frawley J; O'Donnell JM; Leonard BE
    Pharmacol Biochem Behav; 2000 Mar; 65(3):389-98. PubMed ID: 10683478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular mechanisms in the actions of morphine and viminol (R2) on rat striatum.
    Carenzi A; Guidotti A; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1975 Aug; 194(2):311-8. PubMed ID: 239224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphine-induced changes in striatal dopamine mechanisms not evoked from the dopamine nerve terminals.
    Andén NE; Grabowska-Andén M
    J Pharm Pharmacol; 1978 Nov; 30(11):732-4. PubMed ID: 31444
    [No Abstract]   [Full Text] [Related]  

  • 55. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug conditioning induced by intrastriatal apomorphine administration.
    Pinheiro Carrera M; Brunhara FC; Schwarting RK; Tomaz C
    Brain Res; 1998 Apr; 790(1-2):60-6. PubMed ID: 9593824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Eur J Pharmacol; 1987 Jul; 139(3):363-4. PubMed ID: 3666014
    [No Abstract]   [Full Text] [Related]  

  • 60. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.